Form Type: 4

SEC EDGAR Link
Accession Number:0000874015-19-000087
Date:2019-07-01
Issuer: IONIS PHARMACEUTICALS INC (IONS)
Original Submission Date:

Reporting Person:

HOUGEN ELIZABETH L
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT CARLSBAD, CA 92010

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-07-01 J 105 a $45.70 20,055 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 reporting 105 shares acquired under the ionis pharmaceuticals, inc. amended and restated 2000 employee stock purchase plan on july 1, 2019. these 105 shares may not be sold until january 2, 2020.
WhaleWisdom Logo

Elevate your investments